ESTRO Brachytherapy for Prostate Cancer 2018

4 larger studies complications and outcome

Heidenreich et al 2010 / ESTRO 2012

Ward et al

Stephenson Gheiler et al

Heidenreich

Year of SRP 1990-2000 1993-2003

1992-1997

2004-2008

Year of RT 1985-1997 1980-2000

1980-1996

2000-2006

No patients

89

60

40

188

Median time to SRP(months)

40

50

58

28

PSA> 10ng/ml

29%

41%

48%

18.4%

< pT2c

39%

35%

43%

71.4%

complications

27%

13%

17%

9%

Rectal injury

3%

2%

3%

1.7%

Urinary continence Transfusion rates

56%

68%

50%

81%

-

29%

-

4.1%